Quality of life (at the time of · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death or dependency at end of · people with acute ischemic stroke
Calcium antagonists showed no clear difference in death or dependency at end of compared with placebo (moderate certainty).
1 finding from 1 review
Death at the end of · people with acute ischemic stroke
Nimodipine showed no clear difference in death at the end of compared with placebo (moderate certainty).
1 finding from 1 review
Recurrence of stroke at the end of · people with acute ischemic stroke
Nimodipine showed no clear difference in recurrence of stroke at the end of compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events during treatment period · people with acute ischemic stroke
Nimodipine showed no clear difference in adverse events during treatment period compared with placebo (moderate certainty).
1 finding from 1 review
Hypotension · people with acute ischemic stroke
Nimodipine showed no clear difference in hypotension during treatment period compared with placebo (moderate certainty).
1 finding from 1 review
Systolic blood pressure · people with acute ischemic stroke
Nimodipine showed no clear difference in mean systolic blood pressure during or at end of treatment compared with placebo (low certainty).
1 finding from 1 review
Death or dependency at end of · people with acute ischemic stroke
Flunarizine showed no clear difference in death or dependency at end of compared with placebo (low certainty).
1 finding from 1 review
Death at the end of treatment · people with acute ischemic stroke
Flunarizine showed no clear difference in death at the end of treatment compared with placebo (low certainty).
1 finding from 1 review
Death at the end of · people with acute ischemic stroke
Flunarizine may leads to higher death at the end of compared with placebo (low certainty).
1 finding from 1 review
Recurrence of stroke at the end of · people with acute ischemic stroke
Flunarizine showed no clear difference in recurrence of stroke at the end of compared with placebo (low certainty).
1 finding from 1 review
Adverse events during treatment period · people with acute ischemic stroke
Flunarizine may leads to higher adverse events during treatment period compared with placebo (low certainty).
1 finding from 1 review
Death at the end of treatment · people with acute ischemic stroke
Calcium antagonists showed no clear difference in death at the end of treatment compared with placebo (moderate certainty).
1 finding from 1 review
Hypotension · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Systolic blood pressure · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death or dependency at end of · people with acute ischemic stroke
Isradipine showed no clear difference in death or dependency at end of compared with placebo (low certainty).
1 finding from 1 review
Death at the end of treatment · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death at the end of · people with acute ischemic stroke
Isradipine showed no clear difference in death at the end of compared with placebo (low certainty).
1 finding from 1 review
Recurrence of stroke at the end of · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events during treatment period · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found